Re­silience nets an­oth­er deal, this time with bil­lion­aire’s can­cer re­search cen­ter

Re­silience is hav­ing a fun week. Fresh off a $625 mil­lion Se­ries D and the launch of a joint ven­ture with MD An­der­son, the bio­man­u­fac­tur­er Re­silience has inked an­oth­er part­ner­ship with an in­flu­en­tial can­cer cen­ter.

Bil­lion­aire Nap­ster founder Sean Park­er’s Park­er In­sti­tute for Can­cer Im­munother­a­py (PI­CI) and Re­silience on Wednes­day cracked open a five-year strate­gic al­liance to de­vel­op and man­u­fac­ture can­cer ther­a­pies gen­er­at­ed from PI­CI’s net­work of im­munother­a­py re­search cen­ters.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER